Cardiology :: Remote device allows cardiologist to monitor patients daily at their homes
An easy-to-use in home monitoring device for patients is changing the way doctors monitor the health of patients with implanted defibrillators.
Cardiologist
Heart Disease :: Few heart disease trials reporting sex specific results
Heart disease differences in men and women continue to be poorly understood because women are included in clinical trials far less than men, and even when women are included, study results are not reported by sex, according to a study in the current issue of Mayo Clinic Proceedings.
Heart :: First keyhole heart valve surgery in UK
First keyhole heart valve surgery on an 89-year-old woman to replace a heart valve would be performed by Doctors at Leicester’s Glenfield Hospital, Leicester UK on Tuesday.
Heart Failure :: New international study to test exercise in heart failure patients
Cardiologists at Wake Forest University Baptist Medical Center are helping to lead a large international study involving 83 other sites that will test 3,000 patients in an effort to determine whether exercise really is good for heart failure patients.
Cure :: Red mushroom a cure for ailments
Red mushroom, the ancient Chinese secret of health and longevity, is emerging as an elixir of life for many in India suffering from various ailments, including cancer, claim doctors in Tamil Nadu and Kerala.
Kidney :: Best treatment approach for narrowed kidney arteries
Whether reopening narrowed kidney arteries benefits patients is a $1.7 billion question a North American study hopes to answer.
Stent :: SCAI president testifies before FDA on safety of drug-eluting stents
In testimony before the Food and Drug Administration (FDA), Gregory J. Dehmer, MD, president of the Society for Cardiovascular Angiography and Interventions (SCAI), today urged a review panel to evaluate new data on the safety of drug-eluting stents (DES) from the perspective of prior developments in the history of coronary intervention, and with an appreciation for the balance of benefits and risks that guides all clinical decision-making.
Stent :: Cypher Coronary stents approved for use by Health Canada
Cordis Corporation, the world’s leading drug-eluting stent manufacturer, today announced the launch of CYPHER SELECT(TM) Plus, the first third-generation drug-eluting stent available for the treatment of Canadian patients with coronary artery disease.
Heart Disease :: Magnets may pose serious risks for patients with pacemakers and ICDs
Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators, according to a study published in the December 2006 edition of Heart Rhythm.
Heart Disease :: Researchers find insect protein effective for treating heart enlargement, arrythmias
Compounds known to play an important role in how insects develop from larvae to adults have been shown in a mouse model for congestive heart failure to be effective in preventing and reducing cardiac cell overgrowth and irregular heart rhythms, according to UC Davis research published in the early online edition of the Proceedings of the National Academy of Sciences.